Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16254919 | 1.00 | HRH3 (0.35) | HRH3KCNH2ACHERECQLGAA | |
| SCHEMBL30341037 | 1.00 | HRH3 (0.35) | HRH3KCNH2ACHERECQLGAA | |
| SCHEMBL18411878 | 1.00 | HRH3 (0.35) | HRH3KCNH2ACHERECQLGAA | |
| SCHEMBL19649547 | 0.98 | RECQL (0.38) | HRH3KCNH2ACHERECQLGAA | |
| SCHEMBL16627509 | 0.98 | RECQL (0.38) | HRH3KCNH2ACHERECQLGAA | |
| SCHEMBL10996925 | 0.97 | HRH3 (0.36) | HRH3KCNH2GAAHPGDALDH1A1 | |
| SCHEMBL18768680 | 0.95 | HRH3 (0.36) | HRH3KCNH2RECQLGAAHPGD | |
| SCHEMBL21160967 | 0.95 | HRH3 (0.36) | HRH3KCNH2RECQLGAAHPGD | |
| SCHEMBL633803 | 0.95 | HRH3 (0.36) | HRH3KCNH2RECQLGAAHPGD | |
| SCHEMBL6496552 | 0.95 | HRH3 (0.36) | HRH3KCNH2RECQLGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1208851-A2 | A medicament for pulmonary drug delivery | ALLIANCE PHARMACEUTICAL CORPORATION (US) | 2002-05-29 | — | — | EP | claimed |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
| WO-2023094594-A1 | SUBSTITUTED DIHYDROPYRANOPYRIDINES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-01 | — | — | WO | disclosed |
| US-20230126893-A1 | [(1,4,5-TRISUBSTITUTED-1H-PYRAZOL-3-YL)SULFANYL]ACETIC ACID DERIVATIVES, SALTS THEREOF, AND USE THEREOF AS ACTIVE HERBICIDAL INGREDIENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-27 | — | — | US | disclosed |
| WO-2022268520-A1 | USE OF SUBSTITUTED PYRROLIDINONES OR THEIR SALTS FOR INCREASING STRESS TOLERANCE OF PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-29 | — | — | WO | disclosed |
| US-20220388971-A1 | [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-08 | — | — | US | disclosed |
| WO-2022200208-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022096449-A1 | [(1,5-DIHETEROARYL-1H-1,2,4-TRIAZOL-3-YL)OXY] ACETIC ACID DERIVATIVES AS SAFENERS FOR THE PROTECTION OF USEFUL PLANTS AND CROP PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096448-A1 | [(5-PHENYL-5-HETEROARYL-1H-PYRAZOL-3-YL)OXY] ACETIC ACID DERIVATIVES AS SAFENERS FOR THE PROTECTION OF USEFUL PLANTS AND CROP PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096446-A1 | [(1-PHENYL-5-(HETEROARYL)-1H-1,2,4-TRIAZOL-3-YL)OXY] ACETIC ACID DERIVATIVES AS SAFENERS FOR THE PROTECTION OF USEFUL PLANTS AND CROP PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-05-12 | — | — | WO | disclosed |
| US-20150216168-A1 | USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2015-08-06 | — | — | US | disclosed |
| WO-2015049351-A1 | USE OF SUBSTITUTED DIHYDRO-OXINDOLYL SULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS | BAYER CROPSCIENCE AG (DE) | 2015-04-09 | — | — | WO | disclosed |
| EP-1019023-B1 | STABILIZED PREPARATIONS FOR USE IN NEBULIZERS | INHALE THERAPEUTIC SYST (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1019020-A1 | STABILIZED BIOACTIVE PREPARATIONS AND METHODS OF USE | Inhale Therapeutic Systems, Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999016421-A1 | STABILIZED BIOACTIVE PREPARATIONS AND METHODS OF USE | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 1999-04-08 | — | — | WO | disclosed |
| US-4599343-A | Perfluoroindolizines and emulsions thereof useful as blood substitutes | THE GREEN CROSS CORPORATION (JP) | 1986-07-08 | — | — | US | disclosed |
| US-4596810-A | Synthetic blood | THE GREEN CROSS CORPORATION (JP) | 1986-06-24 | — | — | US | disclosed |
| US-4591599-A | Perfluoropyrrolizines and emulsions thereof useful as blood substitutes | THE GREEN CROSS CORPORATION (JP) | 1986-05-27 | — | — | US | disclosed |
| US-4526969-A | Trifluoromethyl substituted perfluoro quinolizines | THE GREEN CROSS CORPORATION (JP) | 1985-07-02 | — | — | US | disclosed |
| US-4425347-A | OXYGEN CARRIER | THE GREEN CROSS CORPORATION (JP) | 1984-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230126893-A1 | [(1,4,5-TRISUBSTITUTED-1H-PYRAZOL-3-YL)SULFANYL]ACETIC ACID DERIVATIVES, SALTS THEREOF, AND USE THEREOF AS ACTIVE HERBICIDAL INGREDIENTS | SYMPK, ALDH7A1, AADAC | HRH3 2205/4885KCNH2 1179/4885ACHE 314/4885 |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | PFAS, DDT, NOTUM | HRH3 3705/4885KCNH2 1870/4885ACHE 759/4885 |
| US-20220388971-A1 | [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS | CYP4Z1, GSTO1, AADAC | HRH3 4365/4885KCNH2 3230/4885ACHE 1383/4885 |
| US-20150216168-A1 | USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | ABAT, AAK1, AGXT | HRH3 1877/4885KCNH2 3639/4885ACHE 2299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.